37 Videos + 2 PDFs
File Size = 12.40 GB
In this online CME program, leaders in diagnostic pathology deliver in-depth discussions of microscopic evaluation of hematolymphoid disorders, as well as the appropriate use of a broad range of ancillary studies. Current Concepts in Hematopathology delivers continuing medical education insights, including:
- common pitfalls in the morphologic interpretation and immunophenotyping of hematolymphoid proliferations
- approaches to cases that do not conform to WHO diagnostic categories
- use of evidence-based guidelines, cytogenetics, and molecular testing to inform diagnosis
Learning Objectives
Upon completion of this activity, participants will be able to:
- Correctly use morphologic criteria and cost-effectively use ancillary studies to diagnose a broad range of lymph node and bone marrow pathologies
- Apply evidence-based criteria to the diagnosis of myeloid and lymphoid neoplasms
- Diagnose challenging cases that do not readily conform to well-established entities
- Evaluate and distinguish hematolymphoid malignancies from non-neoplastic mimics of malignancy
Target Audience
This course is targeted to specialty physicians who practice in pathology.
TOPICS / SPEAKERS
Nodal Small B-Cell Lymphomas – Elizabeth A. Morgan, MD
Plasma Cell Neoplasms and Lymphoplasmacytic Lymphoma – Valentina Nardi, MD
Question & Answer – Robert P. Hasserjian, MD – Moderator, Elizabeth A. Morgan, MD and Valentina Nardi, MD
Immunodeficiency and Viral-Associated Lymphoproliferations – Judith A. Ferry, MD
Updates in Cutaneous Lymphomas – Sam Sadigh, MD
Question & Answer – Elizabeth A. Morgan, MD – Moderator, Judith A. Ferry, MD and Sam Sadigh, MD
WHO Update – Follicular Lymphoma and Related Entities – Abner Louissaint Jr., MD, PhD
Diffuse Large B-Cell Lymphoma Subtypes – Scott B. Lovitch, MD, PhD
Question & Answer – Marian H. Harris, MD – Moderator, Abner Louissaint Jr, MD, PhD and Scott B. Lovitch, MD, PhD
Burkitt Lymphoma and High-Grade B-Cell Lymphomas – A Practical Guide and Update – Aliyah R. Sohani, MD
Reactive Lymphadenopathies and Castleman Disease – Yasodha Natkunam, MD, PhD
Question & Answer – Robert P. Hasserjian, MD – Moderator, Yasodha Natkunam, MD, PhD and Aliyah R. Sohani, MD
Approach to Peripheral Smear Review – Elizabeth Courville, MD
Myelodysplastic Syndrome and Its Differential Diagnosis – Robert P. Hasserjian, MD
Question & Answer – Elizabeth A. Morgan, MD – Moderator, Elizabeth Courville, MD and Robert P. Hasserjian, MD
Acute Myeloid Leukemia and Acute Leukemias of Ambiguous Lineage – Olga K. Weinberg, MD
Acute Lymphoblastic Leukemia – Marian H. Harris, MD, PhD
Question & Answer – Robert P. Hasserjian, MD – Moderator, Marian H. Harris, MD, PhD and Olga K. Weinberg, MD
Eosinophilia and Mastocytosis – Olga Pozdnyakova, MD, PhD
Myelodysplastic/Myeloproliferative Neoplasms – Robert P. Hasserjian, MD
Question & Answer – Marian H. Harris, MD, PhD – Moderator, Robert P. Hasserjian, MD and Olga Pozdnyakova, MD, PhD
Interpreting Flow Cytometry Minimal Residual Disease in Acute Leukemia – Sa A. Wang, MD
Practical Interpretation of Molecular Testing in Myeloid Neoplasms – Annette S. Kim, MD, PhD
Question & Answer – Elizabeth A. Morgan, MD – Moderator, Annette S. Kim, MD, PhD and Sa A. Wang, MD
Challenges in the Diagnosis of Hodgkin Lymphomas – Marian H. Harris, MD, PhD
Primary Mediastinal Large B-Cell and Grey-Zone Lymphomas – Scott J. Rodig, MD, PhD
Question & Answer – Robert P. Hasserjian, MD – Moderator, Marian H. Harris, MD, PhD and Scott J. Rodig, MD, PhD
Indolent T-Cell Disorders – Kathleen H. Burns, MD, PhD
Nodal T-Cell Lymphomas – Roberto Chiarle, MD
Question & Answer – Marian H. Harris, MD, PhD – Moderator, Kathleen H. Burns, MD, PhD and Roberto Chiarle, MD
Histiocytic and Dendritic Cell Neoplasms – Elizabeth A. Morgan, MD
IgG4-Related Disease and Lymphadenopathy – Jacob R. Bledsoe, MD
Blastic Plasmacytoid Dendritic Cell Neoplasm – Gabriel K. Griffin, MD
Question & Answer – Marian H. Harris, MD, PhD – Moderator, Jacob R. Bledsoe, MD, Gabriel K. Griffin, MD and Elizabeth A. Morgan, MD
Inherited Predisposition to Myeloid (and Hematological) Malignancies – Mark D. Fleming, MD, DPhil
Spleen Pathology – Lawrence R. Zukerberg, MD
Question & Answer – Elizabeth A. Morgan, MD – Moderator, Mark D. Fleming, MD, DPhil and Lawrence R. Zukerberg, MD
Date of Original Release:Â June 30, 2022
Termination Date:Â June 30, 2025
